Vasoactive neuropeptides in autoimmune diseases

Date of this Version


Document Type

Book Chapter

Publication Details

Published Version.

Brenu, E. W., Tajouri, L., Staines, D. R., & Marshall-Gradisnik, S. M. (2011). Vasocative neuropeptides in autoimmune diseases. In F-P. Huang (Ed.), Autoimmune disorders - Current concepts and advances from bedside to mechanistic insights (pp. 455-476). Rijeka, Croatia: InTech.

Access the publisher's website.

2011 HERDC submission. FoR code: 110703

© Copyright InTech, 2011.

All chapters are Open Access articles distributed under the Creative Commons
Non Commercial Share Alike Attribution 3.0 license, which permits to copy, distribute, transmit, and adapt the work in any medium, so long as the original work is properly cited. After this work has been published by InTech, authors have the right to republish it, in whole or part, in any publication of which they are the author, and to make other personal use of the work. Any republication, referencing or personal use of the work must explicitly identify the original source.




Neuropeptides are a class of regulatory peptides with effects in nearly all physiological systems and processes. They are important in facilitating neuroendocrine immune interactions. Bi-directional communication between these two systems in both the central nervous system (CNS) and the periphery are arbitrated by the presence of these peptidergic innervations. These innervations interacting through unique ligand receptor binding complexes have immunomodulatory effects that preserve neuroendocrine and neuroimmune health.



This document has been peer reviewed.